Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

23.76
-0.2400-1.00%
Post-market: 23.75-0.0100-0.04%19:38 EDT
Volume:985.86K
Turnover:23.35M
Market Cap:3.80B
PE:-8.38
High:24.01
Open:23.72
Low:23.41
Close:24.00
52wk High:27.30
52wk Low:12.58
Shares:159.85M
Float Shares:151.07M
Volume Ratio:1.04
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8353
EPS(LYR):-2.9700
ROE:-54.93%
ROA:-29.15%
PB:4.55
PE(LYR):-8.00

Loading ...

Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Major Issues Report

Form 8-K - Current report